A detailed history of Citigroup Inc transactions in Baxter International Inc stock. As of the latest transaction made, Citigroup Inc holds 282,093 shares of BAX stock, worth $11.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
282,093
Previous 555,504 49.22%
Holding current value
$11.1 Million
Previous $23.7 Million 60.26%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$32.87 - $43.55 $8.99 Million - $11.9 Million
-273,411 Reduced 49.22%
282,093 $9.44 Million
Q1 2024

May 10, 2024

BUY
$37.88 - $43.77 $592,215 - $684,300
15,634 Added 2.9%
555,504 $23.7 Million
Q4 2023

Feb 09, 2024

SELL
$31.71 - $38.95 $1.17 Million - $1.44 Million
-36,943 Reduced 6.4%
539,870 $20.9 Million
Q3 2023

Nov 09, 2023

BUY
$37.32 - $49.29 $2.13 Million - $2.82 Million
57,165 Added 11.0%
576,813 $21.8 Million
Q2 2023

Aug 10, 2023

SELL
$39.98 - $47.68 $59.4 Million - $70.8 Million
-1,484,842 Reduced 74.08%
519,648 $23.7 Million
Q1 2023

May 11, 2023

BUY
$37.58 - $52.57 $57.4 Million - $80.3 Million
1,527,920 Added 320.61%
2,004,490 $81.3 Million
Q4 2022

Feb 09, 2023

SELL
$49.7 - $57.71 $7.35 Million - $8.54 Million
-147,958 Reduced 23.69%
476,570 $24.3 Million
Q3 2022

Nov 10, 2022

BUY
$53.86 - $66.8 $7.64 Million - $9.48 Million
141,926 Added 29.41%
624,528 $33.6 Million
Q2 2022

Aug 10, 2022

SELL
$63.83 - $80.0 $9.46 Million - $11.9 Million
-148,200 Reduced 23.49%
482,602 $31 Million
Q1 2022

May 12, 2022

BUY
$76.85 - $89.45 $9.17 Million - $10.7 Million
119,328 Added 23.33%
630,802 $48.9 Million
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $7.3 Million - $8.53 Million
-97,853 Reduced 16.06%
511,474 $43.9 Million
Q3 2021

Nov 10, 2021

BUY
$73.77 - $83.61 $45 Million - $50.9 Million
609,327 New
609,327 $49 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.